MedPath

Effect of Electroacupuncture in Patients With Sepsis Associated Brain Injury

Not Applicable
Conditions
Sepsis
Electroacupuncture
Sepsis-associated Brain Injury
Interventions
Other: shame electroacupuncture
Other: electroacupuncture
Registration Number
NCT05171699
Lead Sponsor
Tianjin Nankai Hospital
Brief Summary

To investigate the effect of electroacupuncture on patients with sepsis-associated brain injury.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. Age is between 20 and 80 years.
  2. Patients meeting the diagnosis of sepsis-associated brain injury.
  3. Patients who agreed to accept this trial and signed the informed consent form.
Exclusion Criteria
  1. Patients with a history of brain injury, stroke, epilepsy, cognitive impairment, or mental illness prior to admission.
  2. Patients who were also involved in any other interventional study.
  3. Due to hearing or vision loss, or any other situation that may seriously interfere with study data collection.
  4. Patients who refused to participate in this study.
  5. The pregnancy test was positive or is currently breastfeeding.
  6. Any other situation that the investigator believed might be detrimental to participant in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
shame electroacupunctureshame electroacupunctureThe shame electroacupuncture were performed at a shallow depth and 1 mm lateral to Zusanli (ST36) and Baihui (DU20) acupoints.
electroacupunctureelectroacupunctureThe investigators choose Zusanli (ST36) and Baihui (DU20) acupoints to investigate the effect of electroacupuncture on patients with sepsis-associated brain injury.
Primary Outcome Measures
NameTimeMethod
neuron specific enolase,NSEChange of NSE from Baseline at 7 days

Serum index of sepsis-associated brain injury.

sTREM2Change of sTREM2 from Baseline at 7 days

Serum index of sepsis-associated brain injury.

soluble protein-100β,S100βChange of S100β from Baseline at 7 days

Serum index of sepsis-associated brain injury.

Secondary Outcome Measures
NameTimeMethod
Montreal Cognitive Assessment (MoCA) scaleChange of MoCA from Baseline at 7 days

Rapid screening for cognitive function abnormalities。

Acute Physiology and Chronic Health Evaluation,APACHE IIChange of APACHE II from Baseline at 7 days

To assess the severity of the disease.

Glasgow Coma Scale,GCSChange of GCS from Baseline at 7 days

To assess the degree of coma.

Trial Locations

Locations (1)

Tianjin Nankai Hospital

🇨🇳

Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath